Browse Data and Analysis

In September 2024, a National Assembly member submitted a draft revision of the Act on Transboundary Movements of Living Modified Organisms, commonly referred to as the LMO Act.

In January 2024, Nigeria became the second country in Africa to approve the commercial release of four biotech (TELA) maize varieties.

In January 2024, Nigeria approved the commercial release of four TELA maize varieties, which have been genetically engineered for improved insect-resistance and drought-tolerance. In addition to South Africa, Nigeria has become the second country in...

Korea has not finalized the May 2021 revisions of its Living Modified Organism (LMO) Act, which defines Korea’s regulatory policies for products developed through innovative technologies including genome editing.

In July 2023, President Tinubu declared an "immediate state of emergency on food insecurity" to address high food prices and lackluster agricultural production. Nigeria is considered by some in Africa to be a leader in agricultural biotechnology as it has researched, tested, evaluated, and commercialized several biotech products, including cowpea, a staple crop for smallholder farmers across West Africa.

Nigeria has taken an increasingly active role in biotechnology research and development in Africa – spurred by the solid support of the Government of Nigeria (GON). In September 2022, Nigeria hosted regulators from Mozambique and Ethiopia to learn more about Nigeria’s biotechnology regulatory experience.

The Republic of Korea (ROK) has joined international commitments to reach carbon neutrality by 2050 and passed a Carbon Neutrality Act in 2021 to promote green growth. Although the agricultural industry will be relatively less impacted than some other sectors (including energy), agricultural producers will need to make some adjustments.

Nigeria continues to deliver notable achievements in biotechnology research and development – spurred by strong support of the Government of Nigeria (GON).

Korea is in the process of revising its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.

In December 2020, the Government of Nigeria through the National Biosafety Management Agency (NBMA) authorized guidelines on gene editing.

Since the commercial release of Bt Cowpea in January 2019, Nigeria biotech regulatory authorities are forging ahead with other approvals.

Korea is in the process of drafting a proposal to revise its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.